FIGS

Direct-to-consumer healthcare apparel brand

Culver City, California, United States

About FIGS

FIGS specializes in healthcare apparel, particularly focusing on scrubs and other clothing for medical professionals like doctors and nurses. Their products are designed to combine comfort, durability, functionality, and style, making them appealing in a market that often lacks innovation. FIGS operates on a direct-to-consumer model, which allows them to sell their products directly to customers without intermediaries, ensuring better control over brand experience and pricing. This approach enables FIGS to offer high-quality apparel at competitive prices while building a loyal customer base. The company's goal is to celebrate and empower healthcare professionals by providing them with advanced workwear solutions that meet their needs.

Culver City, CaliforniaHeadquarters
2013Year Founded
$70MTotal Funding
IPOCompany Stage
Healthcare, Consumer GoodsIndustries
201-500Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
401(k) Company Match
Unlimited Paid Time Off
Paid Vacation
Parental Leave
Wellness Program
Employee Discounts

Risks

Increased competition could erode FIGS' market share in healthcare apparel.
Counterfeit products online may damage FIGS' brand reputation and consumer trust.
Supply chain vulnerabilities could lead to production delays and increased costs.

Differentiation

FIGS offers antimicrobial, wrinkle-resistant, and stain-repellant scrubs with four-way stretch.
The company operates a direct-to-consumer model, enhancing brand control and customer experience.
FIGS' partnership with the US Olympic Committee boosts its brand visibility and credibility.

Upsides

FIGS' DTC platform is the largest in the healthcare apparel industry.
The partnership with Team USA extends through the 2028 Olympics, enhancing brand exposure.
Growing demand for healthcare workwear supports FIGS' market expansion opportunities.

Funding

Total raised$70.04 M
Latest valuation$4.40 B
StageIPO
IPO
4/30/2021
$581
$4.40 B
SERIES B
12/31/2017
$65
$325.00 M
SEED
6/30/2013
$2
$10.00 M